Financial Summary (All financials)
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 7.8 | 3.9 | 0.6 | 0.3 |
| Revenue growth | 100.1% | 585.3% | 94.5% | |
| Cost of goods sold | 12.8 | 9.2 | 4.5 | 1.9 |
| Gross profit | -5.0 | -5.3 | -4.0 | -1.6 |
| Gross margin | -64.0% | -135.3% | -697.0% | -550.5% |
| Selling, general and administrative | 15.4 | 14.4 | 8.0 | 4.6 |
| Research and development | 4.3 | 8.7 | 7.2 | 4.8 |
| EBIT | -24.7 | -28.4 | -19.1 | -11.1 |
| EBIT margin | -315.9% | -727.2% | -3354.9% | -3781.6% |
| Pre-tax income | -26.7 | -29.0 | -19.4 | -11.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | | 0.0% |
| Net income | -26.7 | -29.0 | -19.4 | -11.2 |
| Net margin | -341.8% | -742.0% | -3407.5% | -3809.2% |
| |
| Diluted EPS | ($0.21) | ($0.31) | ($0.26) | ($0.32) |
| Shares outstanding (diluted) | 126.3 | 93.5 | 74.8 | 35.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|